RVX
$0.04
-11.111%

Resverlogix Corp.
Insider Activity

Last updated: May 1, 2025, 8:53 PM ET

Profile

Company Description

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

Sector

Healthcare

Industry

Biotechnology

Insider Activity

Financial Data provided by QuoteMedia captures transactions reported on SEDI. To view this company’s financial statements, please visit the Financials & Filings.

Time Range
3 Months
BUYING/SELLING BY INSIDER
Buys
3
months
2 Buys
# of Shares 350,000
Sells
3
months
1 Sells
# of Shares 300,000